FDA EIR - Silicones Plus Inc - November 18, 2013

A routine, comprehensive FDA inspection of Silicones Plus Inc., an ingredient distributor located in Arlington, TX, took place on November 6, 2013. This marked the firm's initial regulatory inspection. The assessment covered various operational aspects, including the company's procedures for receiving, storing, distributing, and ensuring sanitation across its facilities. Silicones Plus Inc. supplies a diverse range of materials, including silicone raw materials for personal care applications, chondroitin and glucosamine for nutraceutical products, and specialized food process aids like anti-foam agents. The inspection was conducted under established regulatory guidelines, specifically CP 7303.803 for Domestic Food Safety and CP 7329.001 for Cosmetics and Import/Domestic Programs. A key finding was the absence of any deficiencies or violations; thus, no Form FDA 483 Inspectional Observation was issued. This outcome resulted in a "No Action Indicated" (NAI) classification for the company, signifying full compliance. Consequently, no immediate corrective actions were mandated for Silicones Plus Inc. A subsequent routine re-inspection is scheduled for November 2014 to continue regulatory oversight.